Empagliflozin Mechanism, Clinical Applications, and Therapeutic Impact in Diabetes and Cardiovascular Disease

Innovative Research Journals

 Empagliflozin Mechanism, Clinical Applications, and Therapeutic Impact in Diabetes and Cardiovascular Disease Introduction Empagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor widely used in the management of type 2 diabetes mellitus (T2DM) and associated cardiovascular and renal comorbidities. Marketed under the brand […]

Read More

Understanding Reduced Ejection Fraction Pathophysiology, Diagnosis, and Management

Innovative Research Journals

Understanding Reduced Ejection Fraction Pathophysiology, Diagnosis, and Management Introduction Reduced ejection fraction (REF), commonly referred to as heart failure with reduced ejection fraction (HFrEF), is a serious and progressive condition in which the heart muscle cannot pump blood effectively. This impairment leads […]

Read More

Lewy Bodies Pathological Hallmarks, Mechanisms, and Clinical Implications

Innovative Research Journals

Lewy Bodies Pathological Hallmarks, Mechanisms, and Clinical Implications Introduction Lewy bodies are abnormal aggregates of protein that develop inside nerve cells, primarily affecting brain regions involved in cognition, movement, and behavior. These intracellular inclusions are a key pathological hallmark of several neurodegenerative […]

Read More